Published in Circulation on April 09, 2002
Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials (2008) 1.79
Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke. Arch Neurol (2008) 1.59
The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology (2008) 1.58
Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol (2010) 1.55
Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry (2006) 1.52
Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study. J Neurol Neurosurg Psychiatry (2007) 1.36
Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke (2007) 1.29
Diagnostic performance of liquid crystal and cathode-ray-tube monitors in brain computed tomography. Eur Radiol (2003) 1.08
Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry (2005) 1.01
Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review. Br J Clin Pharmacol (2012) 0.99
Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence. J Cereb Blood Flow Metab (2011) 0.99
Safety and efficacy of alteplase in the treatment of acute ischemic stroke. Vasc Health Risk Manag (2009) 0.98
Hyperglycemia, acute ischemic stroke, and thrombolytic therapy. Transl Stroke Res (2014) 0.95
Advanced imaging improves prediction of hemorrhage after stroke thrombolysis. Ann Neurol (2013) 0.95
ICD9 codes cannot reliably identify hemorrhagic transformation of ischemic stroke. Circ Cardiovasc Qual Outcomes (2013) 0.90
Thrombolysis, stroke-unit admission and early rehabilitation in elderly patients. Nat Rev Neurol (2009) 0.90
Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post-Thrombolysis: Findings From Get With The Guidelines-Stroke. J Am Heart Assoc (2015) 0.89
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. Vasc Health Risk Manag (2014) 0.88
Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis. Cerebrovasc Dis (2009) 0.86
A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial. Trials (2010) 0.86
Prestroke dementia is associated with poor outcomes after reperfusion therapy among elderly stroke patients. J Stroke Cerebrovasc Dis (2011) 0.86
Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke. J Neurol (2008) 0.84
Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial. Ann N Y Acad Sci (2012) 0.83
Antiplatelet therapy and the risk of intracranial hemorrhage after intravenous tissue plasminogen activator therapy for acute ischemic stroke. Arch Neurol (2008) 0.81
Rapid formation of cerebral microbleeds after carotid artery stenting. Cerebrovasc Dis Extra (2012) 0.80
Safety and Efficacy of Acute Clopidogrel Load in Patients with Moderate and Severe Ischemic Strokes. Stroke Res Treat (2016) 0.79
Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke. Neurohospitalist (2015) 0.79
Baseline serum glucose concentration and symptomatic haemorrhagic transformation in non-diabetic stroke patients treated by intravenous thrombolysis. J Neurol (2013) 0.78
Leukoaraiosis on magnetic resonance imaging is related to long-term poor functional outcome after thrombolysis in acute ischemic stroke. J Korean Neurosurg Soc (2011) 0.78
Permeability Parameters Measured with Dynamic Contrast-Enhanced MRI: Correlation with the Extravasation of Evans Blue in a Rat Model of Transient Cerebral Ischemia. Korean J Radiol (2015) 0.78
Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications. Neurohospitalist (2015) 0.78
SOD1 overexpression prevents acute hyperglycemia-induced cerebral myogenic dysfunction: relevance to contralateral hemisphere and stroke outcomes. Am J Physiol Heart Circ Physiol (2014) 0.78
Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta-analysis of 19 Studies. J Am Heart Assoc (2016) 0.78
The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in the pre-endovascular era. Neurol Med Chir (Tokyo) (2014) 0.77
Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system. Eur J Clin Pharmacol (2013) 0.76
Increased Risk of Post-Thrombolysis Intracranial Hemorrhage in Acute Ischemic Stroke Patients with Leukoaraiosis: A Meta-Analysis. PLoS One (2016) 0.76
Does preexisting antiplatelet treatment influence postthrombolysis intracranial hemorrhage in community-treated ischemic stroke patients? An observational study. Acad Emerg Med (2013) 0.76
The role of additional computed tomography in the decision-making process on the secondary prevention in patients after systemic cerebral thrombolysis. Ther Clin Risk Manag (2015) 0.75
Successful recanalization post endovascular therapy is associated with a decreased risk of intracranial haemorrhage: a retrospective study. BMC Neurol (2015) 0.75
A Retrospective Study of thrombolysis with 0.6 mg/kg Recombinant Tissue Plasminogen Activator (rt-PA) in Mild Stroke. Sci Rep (2016) 0.75
Acute Middle Cerebral Artery Occlusion Treated by Thrombectomy in a Patient with Myelodysplastic Syndrome and Severe Thrombocytopenia. J Vasc Interv Neurol (2015) 0.75
Blood Occludin Level as a Potential Biomarker for Early Blood Brain Barrier Damage Following Ischemic Stroke. Sci Rep (2017) 0.75
Detection of Early Ischemic Changes in Noncontrast CT Head Improved with "Stroke Windows". ISRN Neurosci (2014) 0.75
Adverse outcome of early recurrent ischemic stroke secondary to atrial fibrillation after repeated systemic thrombolysis. Case Rep Vasc Med (2013) 0.75
Identifying the stroke victim at risk for hemorrhage during thrombolysis. Circulation (2002) 0.75
Visible Thrombolysis Acceleration of a Nanomachine Powered by Light-Driving F0F1-ATPase Motor. Nanoscale Res Lett (2015) 0.75
Mobilization after thrombolysis (rtPA) within 24 hours of acute stroke: what factors influence inclusion of patients in A Very Early Rehabilitation Trial (AVERT)? BMC Neurol (2014) 0.75
Prestroke Antiplatelet Effect on Symptomatic Intracranial Hemorrhage and Functional Outcome in Intravenous Thrombolysis. J Stroke (2016) 0.75
Remote cerebral hematomas in patients treated with intravenous rt-PA. J Neurol (2010) 0.75
Dual anti-ischemic effects of rosmarinic acid n-butyl ester via alleviation of DAPK-p53-mediated neuronal damage and microglial inflammation. Acta Pharmacol Sin (2017) 0.75
Severe cerebral hypovolemia on perfusion CT and lower body weight are associated with parenchymal haemorrhage after thrombolysis. Neuroradiology (2016) 0.75
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke. Acta Neuropathol (2017) 0.75
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet (2007) 10.74
Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet (2007) 8.68
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med (2015) 6.96
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med (2004) 5.32
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21
Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol (2007) 3.72
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke (2007) 2.93
Methodology of the Interventional Management of Stroke III Trial. Int J Stroke (2008) 2.88
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke (2010) 2.79
A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J (2005) 2.47
The safety and efficacy of thrombolysis for strokes after cardiac catheterization. J Am Coll Cardiol (2008) 2.38
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36
Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2012) 2.34
Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke (2009) 2.26
Reliability of assessing percentage of diffusion-perfusion mismatch. Stroke (2003) 2.22
Standardized prehospital treatment of stroke. Dtsch Arztebl Int (2011) 2.21
Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol (2010) 2.12
Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Stroke (2006) 2.04
Comprehensive stroke centers overcome the weekend versus weekday gap in stroke treatment and mortality. Stroke (2011) 2.01
Long-term changes in serum cholesterol level does not influence the progression of coronary calcification. Int J Cardiol (2010) 1.99
Comparison of magnesium status using X-ray dispersion analysis following magnesium oxide and magnesium citrate treatment of healthy subjects. Magnes Res (2012) 1.98
Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke (2002) 1.97
CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke (2012) 1.92
When to expect negative diffusion-weighted images in stroke and transient ischemic attack. Stroke (2008) 1.88
Intracranial atherosclerotic disease: an update. Ann Neurol (2009) 1.86
Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation (2008) 1.84
Recurrent events in transient ischemic attack and minor stroke: what events are happening and to which patients? Stroke (2008) 1.81
Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack? Stroke (2006) 1.80
Multiphase CT Angiography: A New Tool for the Imaging Triage of Patients with Acute Ischemic Stroke. Radiology (2015) 1.73
Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial. J Neuroimaging (2004) 1.69
Streamlining of prehospital stroke management: the golden hour. Lancet Neurol (2013) 1.69
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke (2012) 1.68
Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol (2005) 1.67
Intravenous alteplase for stroke in those older than 80 years old. Stroke (2010) 1.65
Microvascular brain pathology and late-life motor impairment. Neurology (2013) 1.64
Hyperfibrinogenemia and functional outcome from acute ischemic stroke. Stroke (2009) 1.63
Optical bedside monitoring of cerebral blood flow in acute ischemic stroke patients during head-of-bed manipulation. Stroke (2014) 1.62
Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke (2003) 1.61
Sulfonylurea use before stroke does not influence outcome. Stroke (2011) 1.60
Impact of a stroke unit on length of hospital stay and in-hospital case fatality. Stroke (2008) 1.59
Effect of baseline CT scan appearance and time to recanalization on clinical outcomes in endovascular thrombectomy of acute ischemic strokes. Stroke (2010) 1.58
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood (2008) 1.57
Predictors of outcome in childhood intracerebral hemorrhage: a prospective consecutive cohort study. Stroke (2009) 1.56
Prevalence and clinical predictors of reverse remodeling in patients with dilated cardiomyopathy. Isr Med Assoc J (2014) 1.56
CT-NIHSS mismatch does not correlate with MRI diffusion-perfusion mismatch. Stroke (2007) 1.55
Stroke- on- Awakening: Safety of CT-CTA Based Selection for Reperfusion Therapy. Can J Neurol Sci (2014) 1.55
Middle cerebral artery vasospasm: transcranial color-coded duplex sonography versus conventional nonimaging transcranial Doppler sonography. Crit Care Med (2009) 1.53
Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke (2008) 1.51
Brain hypoxia is associated with short-term outcome after severe traumatic brain injury independently of intracranial hypertension and low cerebral perfusion pressure. Neurosurgery (2011) 1.51
Utility of the NIH Stroke Scale as a predictor of hospital disposition. Stroke (2003) 1.51
Emotional neglect in childhood and cerebral infarction in older age. Neurology (2012) 1.50
Computed tomographic parameters predicting fatal outcome in large middle cerebral artery infarction. Cerebrovasc Dis (2003) 1.49
Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke (2005) 1.48
CT angiographic source images predict outcome and final infarct volume better than noncontrast CT in proximal vascular occlusions. Stroke (2011) 1.48
Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke (2006) 1.47
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
Transcranial optical monitoring of cerebrovascular hemodynamics in acute stroke patients. Opt Express (2009) 1.46
Relative energy index of microembolic signal can predict malignant microemboli. Stroke (2010) 1.45
Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation (2008) 1.45
The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med (2005) 1.44
Thrombolytic utilization for ischemic stroke in US hospitals with neurology residency program. Neurology (2013) 1.44
Diffusion-weighted imaging-negative patients with transient ischemic attack are at risk of recurrent transient events. Stroke (2007) 1.44
An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke. Int J Stroke (2008) 1.43
Exaggerated blood pressure response to exercise is not associated with masked hypertension in patients with high normal blood pressure levels. J Clin Hypertens (Greenwich) (2014) 1.43
Autoregulation of cerebral blood flow is preserved in primary intracerebral hemorrhage. Stroke (2013) 1.41
Headache as a risk factor for neurovascular events in pediatric brain tumor patients. Neurology (2013) 1.41
Is the maximum dose of 90 mg alteplase sufficient for patients with ischemic stroke weighing >100 kg? Stroke (2011) 1.41
Paracetamol for stroke: easy in practice, but not in trials. Lancet Neurol (2009) 1.41
Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care (2009) 1.40
Virtual TeleStroke support for the emergency department evaluation of acute stroke. Acad Emerg Med (2004) 1.39
Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke (2008) 1.38
Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke (2014) 1.38
Assessment of leptomeningeal collaterals using dynamic CT angiography in patients with acute ischemic stroke. J Cereb Blood Flow Metab (2012) 1.37
Do all age groups benefit from organized inpatient stroke care? Stroke (2009) 1.36
Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke (2010) 1.35
Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke (2010) 1.35
Carotid artery diameter in men and women and the relation to body and neck size. Stroke (2006) 1.35
Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol (2010) 1.32
CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage. J Neurosci (2014) 1.31